Granules India, a Hyderabad-based pharmaceutical company, gained 2.61% to Rs 328.70 on Tuesday, as it entered into a strategic partnership with Greenko ZeroC to collaborate for green molecule solutions and its wider applications in pharmaceuticals to build its position in sustainability and circular economy initiatives. Granules India and Greenko ZeroC will develop and promote a state-of-the-art integrated Green Pharmaceutical Zone (GPZ) with the first collaboration at Kakinada in Andhra Pradesh, the company said in a filing to the exchanges on Tuesday."Granules will build a green field facility based on sustainability principles for large-scale manufacturing of key starting materials (KSMs), Intermediates, APIs, and fermentation-based products. The facility spread across 100 acres, will be commissioned in a phase-wise manner. The facility would be spread across 100 acres for the project with an estimated cost of approximately Rs 2,000 crore over five years.
Read more